Article

Rescigno, Pasquale and Porta, Nuria and Finneran, Laura and Riisnaes, Ruth and Figueiredo, Ines and Carreira, Suzanne and Flohr, Penny and Miranda, Susana and Bertan, Claudia and Ferreira, Ana and Crespo, Mateus and Rodrigues, Daniel Nava and Gurel, Bora and Nobes, Jenny and Crabb, Simon and Malik, Zafar and Ralph, Christy and McGovern, Ursula and Hoskin, Peter and Jones, Robert J. and Birtle, Alison and Gale, Joanna and Sankey, Peter and Jain, Suneil and McLaren, Duncan and Chadwick, Eliot and Espinasse, Aude and Hall, Emma and de Bono, Johann (2024) Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. European Journal of Cancer, 205: 114103. ISSN 0959-8049

Ring, Alistair and Kilburn, Lucy S. and Pearson, Alex and Moretti, Laura and Afshari-Mehr, Angelica and Wardley, Andrew M. and Gurel, Bora and MacPherson, Iain R. and Riisnaes, Ruth and Baird, Richard D. and Martin, Sue and Roylance, Rebecca and Johnson, Hannah and Ferreira, Ana and Winter, Matthew C. and Dunne, Kathryn and Copson, Ellen and Hickish, Tamas and Burcombe, Russell and Randle, Kat and Serra, Violeta and Llop-Guevara, Alba and Bliss, Judith M. and Turner, Nicholas C. (2023) Olaparib and celarasertib (AZD6738) in patients with triple negative advanced breast cancer: results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clinical Cancer Research, 29 (23). pp. 4751-4759. ISSN 1078-0432